#United States #New York #Class Action #Levi & Korsinsky #Replimune Group

Levi & Korsinsky Notifies Investors on Class Action Against Replimune Group

Introduction
Levi & Korsinsky, a prominent law firm, has recently alerted investors regarding a class action lawsuit aimed at the Replimune Group, Inc. The lawsuit draws attention to allegations of securities fraud, claiming adverse impacts on investors during a specific timeline. This article explores the details of the lawsuit, the process for affected investors, and the implications of this legal action.

Details of the Lawsuit
According to the notification, the class action lawsuit is directed at investors who suffered losses due to alleged fraudulent activities surrounding Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024, and July 21, 2025. The firm believes that these investors are entitled to seek reparation for their losses. They can do so by connecting with Levi & Korsinsky for further information about their rights and the process involved.

Claims Made Against Replimune Group
The complaint outlines that the defendants, associated with Replimune Group, allegedly made misleading statements about the IGNYTE trial. Specifically, it claims that the defendants overstated the trial's potential and concealed critical issues that could have jeopardized the outcomes. Consequently, the FDA declared the IGNYTE trial inadequate and poorly controlled, affecting the company’s business narrative significantly. The lawsuit argues that these misleading statements led investors to hold an inaccurate view of the company’s operations and prospects.

What Affected Investors Should Do
Investors affected by the identified losses must take action swiftly. The firm has set a deadline for investors to request the Court to appoint them as lead plaintiffs, which is September 22, 2025. It is crucial to note that being a lead plaintiff is not a prerequisite for participating in any financial recovery that the lawsuit might yield. This means investors can still claim compensation even if they do not wish to take on this specific role in the legal proceedings.

No Cost for Participation
For those impacted, there is no financial burden associated with engaging in this lawsuit. If you qualify as a member of the class action, you may receive compensation without incurring any out-of-pocket expenses. Levi & Korsinsky emphasizes that there is no cost or obligation for individuals to join this process, ensuring access to justice without financial strain.

Expertise of Levi & Korsinsky
With over two decades of experience in securities litigation, Levi & Korsinsky holds a commendable reputation within the legal community, having secured substantial settlements for its clients. Their expertise equips them to navigate complex legal waters effectively, advocating for shareholders' rights and delivering favorable outcomes consistently. The firm, recognized by ISS Securities Class Action Services as one of America’s top litigation firms, continues to fortify its position as a reliable ally for investors in distress.

Contact Information
Affected investors are encouraged to reach out to Levi & Korsinsky for assistance. The law firm's contact details are shared below:

• - Joseph E. Levi, Esq.

Email: [email protected]

• - Phone: (212) 363-7500

Conclusion
For investors in Replimune Group, Inc., this class action lawsuit presents an opportunity to reclaim losses attributed to alleged securities fraud. With the looming deadline, it is imperative to explore options and engage with legal representatives who can provide guidance through the proceedings. Stay informed and proactive to ensure your rights are upheld during this challenging time.